SINO BIOPHARMA | TalkMarkets | Page 1
No data available
No data available

Latest Posts

About This Stock More About This Stock
Week In Review: InvoX, A Sino Biopharma Company, To Pay $161 Million To Acquire F-Star
Article By: ChinaBio® Today
Sunday, June 26, 2022 12:39 PM EDT
InvoX Pharma, a Sino Biopharma subsidiary, will pay $161 million to acquire F-Star, a clinical stage company developing bispecific drugs for immunotherapies. Meanwhile, Reistone Biopharma completed a Series A financing of nearly $100 million.
In this article: AZN, 1177.HK, 600276.SS, 9969.HK, 1477.HK, 0460.HK, FSTX, 6998.HK
Week In Review: Broncus Stages $200 Million Hong Kong IPO For Pulmonary Devices
Article By: ChinaBio® Today
Saturday, September 25, 2021 1:45 PM EDT
Broncus Holding, a Hangzhou pulmonary medical device company, completed a $200 million IPO on the Hong Kong exchange that valued the company at nearly $1.3 billion. The IPO was priced at the top end of the range, but Broncus' shares dropped 20%.
In this article: PFE, 1177.HK, HCM, 2616.HK, 1877.HK, 2162.HK, 9969.HK, 9926.HK, 2216.HK, 2171.HK

Latest Tweets for $1177.HK

No tweets yet!